BioSpace News Archive

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that its wholly owned drug outsourcing facility, US Compounding Inc. (USC), has increased its product mix to provide additional drugs to assist in the ongoing fight against COVID-19.

Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that it has successfully obtained re-registration of the T-SPOT.TB test in China.

Funding will support federally sponsored national Convalescent Plasma Expanded Access Program being led by Mayo Clinic

Amitech Solutions, a leading healthcare data, analytics and automation firm, announces the hire of Tim Branham as Chief Strategy Officer

AvantGen, Inc., a privately-held San Diego-based biotechnology company and contract service provider, today announced it has identified and tested fully human synthetic antibodies (“mAbs”) against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, the “novel Coronavirus”) that show promise for development as diagnostics for SARS-CoV-2 infection and therapeutics for Coronavirus Disease 2019 (COVID-19).

Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announces today that it will host the Company’s 2020 first quarter investor webcast on Tuesday, April 28, 2020 at 2:15 p.m. Mountain Time (4:15 p.m. Eastern Time.

Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to announce the recent allowances of 4 new different US and international patents concerning the Company’s prostate enlargement and prostate cancer treatments

Medical Manufacturing Alliance of South-Central Texas connects supply chain with material, expertise

25 Self-Swab Testing Sites Now Open Across Delaware, Idaho, Michigan, New York, New Jersey, Ohio, Pennsylvania, and Virginia

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced top line data from its Cutaneous Lupus Erythematosus (CLE) study, a chronic autoimmune skin disease, in partnership with Zylö Therapeutics, Inc. for topical administration of Anandamide (AEA)-loaded Z-pods™.